Internal Medicine
RSSArticles
-
Pharmacology Watch: The Indictment of Pharma Industry Marketing Practices
TNF Blockers: Should You Be Concerned?; FDA Actions -
Full October 29, 2006 Issue in PDF
-
Criteria for New Formulary Drugs in PDF
-
Criteria for New Formulary Drugs in PDF
-
Criteria for New Formulary Drugs in PDF
-
Criteria for New Formulary Drugs in PDF
-
Criteria for New Formulary Drugs in PDF
-
Full October 15, 2006 Issue in PDF
-
Pharmacology Watch
A team from UCSF recently reviewed company documents that were entered into the public record as a result of litigation over the promotion of gabapentin (Neurontin) between 1994 and 1998. -
How Low Can You Go?
For hypertensives with coronary artery disease, lowering the diastolic pressure below 70-80 mm Hg appears to create increased risk of morbidity and mortality from myocardial infarction and all-cause death.